Search Constraints
Search Results
Select an image to start the slideshow
Analysis of the Two Isoforms of the Human Alkyl Adenine DNA Glycosylase (HAAG) Gene: A Comparative Study of its Isoforms, its Protein and its Resistance to DNA Damage Agents
1 of 20
DNA Vaccines Against HIV-1: Augmenting Immunogenicity of gp120
2 of 20
Developmentally Interesting Cytokines Upregulated During Human Stem Cell Amplification In Vitro
3 of 20
Telomerase Activity in Human Umbilical Cord Cell Populations Containing Hematopoietic Stem Cells
4 of 20
Analysis of Telomerase Activity and Telomere Lengths in Human Umbilical Cord Cell Populations During Ex Vivo Amplification of Hematopoietic Stem Cells
5 of 20
In Vitro Analysis of FGF-23 Induced Gene Expression
6 of 20
Ependymin Peptide Mimetics That Assuage Ischemic Damage Increase Gene Expression of the Anti-Oxidative Enzyme SOD
7 of 20
Attempts to clone the Limulus ependymin gene, and the effects of a human ependymin peptide on human SHSY neuroblastoma cells
8 of 20
Ependymin Mechanism of Action: Full Length EPN VS Peptide CMX-8933
9 of 20
Telomerase Activity and Telomere Lengths in Fibroblast Cells Treated with Ependymin Peptide Mimetics
10 of 20
AP-1 Is Required For CMX-8933-Induced SOD Upregulation And Is Translocated In Response To A Human EPN Mimetic
11 of 20
Partial Restoration of Cell Survival By A Human Ependymin Mimetic In An In Vitro Alzheimer's Disease Model
12 of 20
Effect of a Codon Optimized DNA Prime on Induction of Anti-Influenza Protective Antibodies
13 of 20
Mechanism of Reversal of Alzheimer's Disease A-beta Induced Neuronal Degeneration in Cultured Human SHSY Cells Using A Neurotrophic Ependymin Mimetic.
14 of 20
Use of a Neurotrophic Factor Mimetic to Block Amyloid Toxicity in Alzheimer's Disease Models
15 of 20
Human Ependymin-1 Neurotrophic Factor Mimetics Reduce Tau Phosphorylation and Cellular Apoptosis in Vitro and in Vivo in Alzheimer's Disease Models
16 of 20
Alzheimer’s Disease: From Pathology and Early Detection to Socioeconomic Impacts and Treatment
17 of 20
Biological, sociological, and economic problems of Alzheimer's Disease.
18 of 20
CANCER CELL TARGETING: WHY ARE SO FEW ANTIBODY-DRUG CONJUGATES FDA APPROVED?
19 of 20
DO CANCER VACCINES REALLY WORK?
20 of 20